Trade Palisade Bio, Inc. - PALI CFD
Add to favourite- Summary
- Historical Data
Spread | 0.16 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 5.85 |
Open | 5.47 |
1-Year Change | 216.18% |
Day's Range | 5.47 - 6.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 23, 2024 | 5.85 | -1.08 | -15.58% | 6.93 | 8.09 | 5.55 |
Apr 22, 2024 | 4.82 | 0.28 | 6.17% | 4.54 | 4.85 | 4.54 |
Apr 19, 2024 | 4.68 | -0.01 | -0.21% | 4.69 | 4.92 | 4.47 |
Apr 18, 2024 | 5.02 | -0.99 | -16.47% | 6.01 | 6.07 | 4.87 |
Apr 17, 2024 | 6.53 | 0.36 | 5.83% | 6.17 | 7.78 | 5.90 |
Apr 16, 2024 | 5.82 | -2.99 | -33.94% | 8.81 | 9.59 | 5.31 |
Apr 15, 2024 | 4.13 | 0.05 | 1.23% | 4.08 | 4.35 | 3.98 |
Apr 12, 2024 | 4.09 | -0.22 | -5.10% | 4.31 | 4.32 | 3.83 |
Apr 11, 2024 | 4.32 | 0.10 | 2.37% | 4.22 | 4.67 | 4.22 |
Apr 10, 2024 | 4.07 | -1.00 | -19.72% | 5.07 | 5.07 | 4.07 |
Apr 9, 2024 | 5.39 | -0.53 | -8.95% | 5.92 | 5.92 | 5.08 |
Apr 8, 2024 | 6.00 | 0.83 | 16.05% | 5.17 | 7.12 | 5.07 |
Mar 28, 2024 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.39 |
Mar 8, 2024 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Mar 7, 2024 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Mar 6, 2024 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Mar 5, 2024 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Mar 1, 2024 | 0.38 | -0.01 | -2.56% | 0.39 | 0.40 | 0.38 |
Feb 29, 2024 | 0.39 | 0.00 | 0.00% | 0.39 | 0.40 | 0.39 |
Feb 28, 2024 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Palisade Bio, Inc. Company profile
About Palisade Bio Inc
Palisade Bio, Inc, formerly Seneca Biopharma, Inc., is a biopharmaceutical company. The Company is focused on developing therapies that helps patients with acute and chronic gastrointestinal problems from post-operative digestive enzyme damage. Its product candidate, LB1148, is a Phase III-ready protease inhibitor which is developed to reduce abdominal adhesions and help restore bowel function following surgery. It is engaged in developing oral product candidates to treat conditions driven by protease (intestinal digestive enzymes) escaping the intestines, including surgical problems and inflammatory conditions. Its LB1148 is an oral formulation of a serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Palisade Bio Inc revenues decreased from $11K to $0K. Net loss increased from $11.8M to $27.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Interest expense increase from $14K to $2.4M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$7.31 to -$3.41.
Equity composition
Common Stock $.01 Par, 03/11, 150M auth., 48,366,304 shares issd. Insiders & Strategic holders own 13.61%. IPO:1/07, 16.3M shares @ $1 per Share.
Industry: | Biotechnology & Medical Research (NEC) |
7750 El Camino Real, Suite 5200
92009
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com